Zhoumou Chen Selected Research

Zhoumou Chen Research Topics

Disease

20	Neuralgia (Stump Neuralgia) 01/2023 - 12/2011
15	Hyperalgesia 11/2022 - 04/2010
15	Pain (Aches) 11/2020 - 10/2010
12	Chronic Pain 10/2020 - 11/2010
4	Multiple Sclerosis 10/2020 - 07/2014
3	Asthma (Bronchial Asthma) 01/2023 - 10/2020
3	Inflammation (Inflammations) 01/2023 - 03/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 05/2012
2	Hypersensitivity (Allergy) 11/2022 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 09/2017
2	Sepsis (Septicemia) 08/2004 - 01/2003
1	Eosinophilia 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Bone Neoplasms (Bone Cancer) 09/2017
1	Hypothermia 02/2016
1	Edema (Dropsy) 01/2013

Drug/Important Bio-Agent (IBA)

9	Analgesics (Analgesic Drugs)IBA 10/2020 - 11/2010
7	Fingolimod Hydrochloride (FTY720)FDA Link 10/2020 - 01/2013
7	Opioid Analgesics (Opioids)IBA 10/2020 - 08/2012
7	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2020 - 03/2011
6	Sphingosine-1-Phosphate ReceptorsIBA 01/2020 - 03/2011
6	SphingolipidsIBA 01/2020 - 08/2011
6	Peroxynitrous Acid (Peroxynitrite)IBA 08/2012 - 10/2010
5	CytokinesIBA 11/2022 - 01/2003
5	Morphine (MS Contin)FDA LinkGeneric 10/2020 - 10/2010
5	CeramidesIBA 09/2017 - 11/2010
5	CarrageenanIBA 01/2013 - 04/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 05/2012
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 05/2012
4	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2015
3	ProdrugsIBA 01/2023 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 11/2022 - 08/2004
3	MRS5698IBA 01/2020 - 01/2015
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 05/2012
3	Bortezomib (Velcade)FDA Link 01/2020 - 05/2012
3	Superoxide DismutaseIBA 10/2010 - 01/2003
2	LigandsIBA 11/2022 - 11/2020
2	Narcotics (Narcotic Analgesics)IBA 11/2020 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2019
2	Naloxone (Narcan)FDA LinkGeneric 01/2020 - 08/2012
2	Adenosine KinaseIBA 06/2018 - 01/2015
2	Adenosine A3 ReceptorIBA 02/2016 - 01/2015
2	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2015 - 05/2012
2	AnionsIBA 01/2015 - 01/2003
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2011 - 10/2010
2	acetovanillone (apocynin)IBA 03/2011 - 10/2010
2	Superoxides (Superoxide)IBA 10/2010 - 01/2003
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 11/2022
1	ArrestinIBA 11/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2022
1	CalciumIBA 11/2020
1	OvalbuminIBA 10/2020
1	naphthaleneIBA 06/2020
1	AcidsIBA 06/2020
1	NLR ProteinsIBA 01/2020
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2020
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2019
1	SphingosineIBA 09/2017
1	TASP0277308IBA 09/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2016
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 02/2016
1	Adenosine A1 ReceptorIBA 02/2016
1	Histamine H4 ReceptorsIBA 02/2016
1	gamma-Aminobutyric Acid (GABA)IBA 01/2015
1	ChloridesIBA 01/2015
1	GABA Plasma Membrane Transport ProteinsIBA 01/2015
1	CannabinoidsIBA 07/2014
1	DDD-028IBA 07/2014
1	Freund's AdjuvantIBA 07/2014
1	Dichlorodiphenyldichloroethane (DDD)IBA 07/2014
1	SEW2871IBA 01/2013
1	sphingosine kinaseIBA 01/2013
1	fucoidanIBA 01/2013
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2013
1	3-nitrotyrosineIBA 08/2012
1	EnkephalinsIBA 08/2012
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Oxidants (Oxidizing Agents)IBA 08/2012
1	taxaneIBA 05/2012
1	PlatinumIBA 05/2012
1	Proteasome InhibitorsIBA 05/2012
1	manganese(III) porphyrinIBA 12/2011
1	ProstaglandinsIBA 08/2011
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2011
1	Phosphotransferases (Kinase)IBA 08/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2011
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 08/2011

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 05/2012
4	Therapeutics 10/2020 - 01/2015
2	Spinal Injections 11/2022 - 11/2020
1	Induced Hypothermia 02/2016
1	Analgesia 01/2015
1	Ligation 07/2014
1	Oral Administration 12/2011